FibroBiologics, Inc. - Common Stock —— 财务报表 (NASDAQ:FBLG) | MetaTrader

展开完整图表完整图表

新闻

EXCLUSIVE: FibroBiologics Targets 2026 Data Readout After Trial Progress For Diabetic Foot Ulcer Study -

美国股市涨跌不一；截至收盘道琼斯工业平均指数上涨0.11%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11%

Upcoming Stock Splits This Week (March 30 to April 2) – Stay Invested - TipRanks.com

FibroBiologics完成糖尿病溃疡试验临床站点准备工作

FibroBiologics completes site onboarding for diabetic ulcer trial

FibroBiologics (FBLG)首席科学官Khoja买入1.14万美元股票

FibroBiologics首席财务官Jason Davis买入28,973美元FBLG股票

FibroBiologics获得骨质疏松症细胞疗法专利

FibroBiologics receives patent for osteoporosis cell therapy

H.C. Wainwright下调FibroBiologics目标价至4美元

H.C. Wainwright cuts FibroBiologics stock price target to $4